Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma

被引：0
|
作者：
Joshua G. Barton
John P. Bois
Michael G. Sarr
Christina M. Wood
Rui Qin
Kristine M. Thomsen
Michael L. Kendrick
Michael B. Farnell
机构：
[1] Mayo Clinic,Department of Surgery, Division of GI and General Surgery
[2] Mayo Clinic,Division of Biostatistics
来源：
Journal of Gastrointestinal Surgery | 2009年 / 13卷
关键词：
Pancreatic carcinoma; Pancreatic ductal carcinoma; CA 19-9 antigen; Survival analysis; Predictive value of tests;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2050 / 2058
页数：8
相关论文
共 50 条
  • [1] Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
    Barton, Joshua G.
    Bois, John P.
    Sarr, Michael G.
    Wood, Christina M.
    Qin, Rui
    Thomsen, Kristine M.
    Kendrick, Michael L.
    Farnell, Michael B.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2009, 13 (11) : 2050 - 2058
  • [2] Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma
    Barton, Joshua G.
    Bois, John P.
    Wood, Christina M.
    Qin, Rui
    Kendrick, Michael L.
    Farnell, Michael B.
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A871 - A871
  • [3] Prognostic value of CA 19-9 level in resectable pancreatic adenocarcinoma
    Rudnicki, J.
    Agrawal, A. K.
    Grzebieniak, Z.
    Zukrowski, P.
    Zysko, D.
    Jelen, M.
    Kielan, W.
    Sebastian, M.
    Slonina, J.
    Marek, G.
    Duda-Barcik, L.
    [J]. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2010, 48 (02) : 249 - 261
  • [4] The Prognostic Value of CEA As a Complementary Tumor Marker of CA 19-9 in Resected Pancreatic Cancer
    Parikh, Dhavan A.
    Azarm, Ali
    Urayama, Shiro
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S659 - S659
  • [5] Prognostic value of CA 19-9 serum course in pancreatic cancer
    Safi, F
    Schlosser, W
    Falkenreck, S
    Beger, HG
    [J]. HEPATO-GASTROENTEROLOGY, 1998, 45 (19) : 253 - 259
  • [6] Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma
    Lee, Kyong Joo
    Yi, Seung Woo
    Chung, Moon Jae
    Park, Seung Woo
    Song, Si Young
    Chung, Jae Bock
    Park, Jeong Youp
    [J]. YONSEI MEDICAL JOURNAL, 2013, 54 (03) : 643 - 649
  • [7] The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates
    Poruk, K. E.
    Gay, D. Z.
    Brown, K.
    Mulvihill, J. D.
    Boucher, K. M.
    Scaife, C. L.
    Firpo, M. A.
    Mulvihill, S. J.
    [J]. CURRENT MOLECULAR MEDICINE, 2013, 13 (03) : 340 - 351
  • [8] The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma
    Sato, Yuki
    Fujimoto, Daichi
    Uehara, Keiichiro
    Shimizu, Ryoko
    Ito, Jiro
    Kogo, Mariko
    Teraoka, Shunsuke
    Kato, Ryoji
    Nagata, Kazuma
    Nakagawa, Atsushi
    Otsuka, Kojiro
    Hamakawa, Hiroshi
    Takahashi, Yutaka
    Imai, Yukihiro
    Tomii, Keisuke
    [J]. BMC CANCER, 2016, 16
  • [9] The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma
    Yuki Sato
    Daichi Fujimoto
    Keiichiro Uehara
    Ryoko Shimizu
    Jiro Ito
    Mariko Kogo
    Shunsuke Teraoka
    Ryoji Kato
    Kazuma Nagata
    Atsushi Nakagawa
    Kojiro Otsuka
    Hiroshi Hamakawa
    Yutaka Takahashi
    Yukihiro Imai
    Keisuke Tomii
    [J]. BMC Cancer, 16
  • [10] Prognostic value of carbohydrate antigen (CA)19-9 decrease in response to chemotherapy for advanced pancreatic adenocarcinoma (PA)
    Cereda, S.
    Rognone, A.
    Mazza, E.
    Passoni, P.
    Zerbi, A.
    Balzano, G.
    Nicoletti, R.
    Arcidiacono, P. G.
    Di Carlo, V.
    Reni, M.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 267 - 267
12345